Among patients with obstructive sleep apnea using CPAP, pitolisant given at 20 mg and 40 mg reduces excessive daytime sleepiness.

Sleep apnea can have untold consequences even in your waking hours. The good news? The condition is treatable.

Obstructive sleep apnea may increase the risk for Parkinson’s disease, but early intervention with continuous positive airway ...

This review included 30 studies to analyze the potential for prolonged life in patients who use CPAP to treat obstructive sleep apnea.

IHL-42X is designed to treat OSA by targeting its underlying pathophysiology. An oral fixed-dose combination of dronabinol and acetazolamide, IHL-42X is currently advancing through the RePOSA Phase ...

OSA, a condition where the airway becomes blocked during sleep, often goes undiagnosed despite its serious health ...

在现代医学研究中，阻塞性睡眠呼吸暂停（Obstructive Sleep ...

The global sleep apnea devices market report consists of exclusive data on 39 vendors. The competitive landscape of sleep apnea devices is dynamic, with multiple players vying for market share through ...